LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.’s Listing on the Main Board of the Hong Kong Stock Exchange

Herbert Smith Freehills has advised China International Capital Corporation as the sole sponsor on the listing of LEPU ScienTech Medical Technology while Wilson Sonsini Goodrich &...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Jenscare Scientific’s Hong Kong IPO

O’Melveny represented Jenscare Scientific Co., Ltd on the deal. Herbert Smith Freehills advised China International Capital Corporation and Citigroup. Jenscare Scientific Co., Ltd. (9877.HK) announced its...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Onewo’s US$738 Million Hong Kong IPO

Paul Hastings and JunHe advised Onewo Inc. on the deal. Herbert Smith Freehills advised CITIC Securities, Citigroup and Goldman Sachs as joint sponsors. Onewo Inc. announced its approximately...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Biocytogen Pharmaceuticals’ Listing on the Main Board of the Hong Kong Stock Exchange

Herbert Smith Freehills has advised Goldman Sachs and China International Capital Corporation as joint sponsors and underwriters. Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced the company’s official listing...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here